Lupin, along with certain U.S. drugmakers and private equity funds, mght be making plans to bid for a selection of older drugs from GlaxoSmithKline, according to Reuters, which cited sources familiar with the dealings.
Walgreens on Tuesday announced the new Balance Rewards for healthy choices initiatives, which is aimed at helping participants modify behavior risk factors associated with the nation's most pressing public health issues.
During the Opening General Session at McKesson’s 2014 ideaShare conference, Frank Starn, SVP and COO of McKesson U.S. Pharmaceutical, and Steve Courtman, president, Health Mart, presented Milwaukee, Wis.-based Hayat Health Mart Pharmacy with the grand prize as the 2014 Pharmacy of the Year award winner.
Even before the official start of this year’s McKesson ideaShare conference, the Gaylord Palms Resort and Convention Center was buzzing with attendees eager to take advantage of the robust lineup of continuing education courses held on Sunday and Monday.
This year’s McKesson ideaShare 2014 kicked off with a bang as thousands of community pharmacy leaders flocked to Orlando, Fla., to participate in the annual event and seize the opportunities to grow in today’s changing healthcare landscape.
Sandoz on Monday announced an agreement with Anacor Pharmaceuticals to obtain exclusive rights to commercialize Kerydin (tavaborole) topical solution, 5%, through its branded dermatology business, PharmaDerm.
Teva Pharmaceutical Industries on Monday announced that its acquistion of Labrys has been completed. The acquisition brings to Teva LBR-101, which is currently in phase-2b clinical trials for prevention of chronic and episodic migraines.
Addressing 3,000 independent pharmacy attendees representing more than 1,000 pharmacies at the McKesson ideaShare 2014, Mark Walchirk, president of McKesson’s U.S. pharmaceutical unit outlined the myriad of opportunities open to community pharmacy today, and how McKesson is investing in its independent pharmacy offerings to help those independents realize every one of those opportunities.
The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.
Industry consolidation continues as CVS Caremark has entered an agreement to snap up regional player Navarro Discount Pharmacy — a move that makes sense for CVS Caremark on several fronts.
Not only does the acquisition strengthen CVS Caremark’s position in the Hispanic marketplace, the fastest growing demographic in the United States, but the deal also includes Navarro Health Services, a specialty pharmacy serving those with complex diseases.
Mylan on Thursday announced that the U.S. District Court for the district of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline in relation to paroxetine CR, the generic version of GSK's Paxil CR.
GSK has begun shipping Fluarix Quadrivalent (influenza vaccine) doses to U.S. healthcare providers, the company annouced. This marks the first shipment of GSK's U.S. flu vaccine supply for the flu season, which follows licensing and lot-release approval from the Food and Drug Administration's Center for Biologics Evaluation and Research.